Targeting Ras-Driven Cancer Cell Survival and Invasion through Selective Inhibition of DOCK1
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Comprehensive Survey of Ras Mutations in Cancer
Prior, I. A., Lewis, P. D., & Mattos, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2612 · Cited by 2,063 · cited 1×
“Accumulating evidence indicates that mutations activating RAS family members, K-RAS, H-RAS, and N-RAS, are found in 20%–30% of human tumors (Cox et al., 2014; Prior et al., 2012; Spiegel et al., 2014), thereby placing thesemutations as major drivers of cancers.”
BackgroundOncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Drugging the undruggable RAS: Mission Possible?
Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4389 · Cited by 1,997 · cited 2×
“Accumulating evidence indicates that mutations activating RAS family members, K-RAS, H-RAS, and N-RAS, are found in 20%–30% of human tumors (Cox et al., 2014; Prior et al., 2012; Spiegel et al., 2014), thereby placing thesemutations as major drivers of cancers.”
BackgroundMacropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., et al. (2013) · Nature · doi:10.1038/nature12138 · Cited by 1,683
Gumienny, T. L., Brugnera, E., Tosello-Trampont, A.-C., Kinchen, J. M., Haney, L. B., Nishiwaki, K., Walk, S. F., Nemergut, M. E., Macara, I. G., Francis, R., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00520-7 · Cited by 568
Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration
Fukui, Y., Hashimoto, O., Sanui, T., Oono, T., Koga, H., Abe, M., Inayoshi, A., Noda, M., Oike, M., Shirai, T., et al. (2001) · Nature · doi:10.1038/35090591 · Cited by 449 · cited 3×
“For example, DOCK2, which is predominantly expressed in hematopoietic cells, plays key roles in migration and activation of leukocytes (Fukui et al., 2001; Gotoh et al., 2008, 2010; Kunisaki et al., 2006; Nishikimi et al., 2009; Sanui et al., 2003).”
BackgroundMethodSelf-citationGrimsley, C. M., Kinchen, J. M., Tosello-Trampont, A.-C., Brugnera, E., Haney, L. B., Lu, M., Chen, Q., Klingele, D., Hengartner, M. O., & Ravichandran, K. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307087200 · Cited by 224 · cited 1×
“However, DOCK1 (also known as DOCK180) and DOCK5 are widely expressed in various tissues and regulate phagocytosis, myoblast fusion, and cell migration (Grimsley et al., 2004; Gumienny et al., 2001; Laurin et al., 2008; Li et al., 2008; Sanematsu et al., 2010).”
BackgroundInherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections
Dobbs, K., Domínguez Conde, C., Zhang, S.-Y., Parolini, S., Audry, M., Chou, J., Haapaniemi, E., Keles, S., Bilic, I., Okada, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413462 · Cited by 201
Gaglio, D., Soldati, C., Vanoni, M., Alberghina, L., & Chiaradonna, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004715 · Cited by 164
Insights into the biological functions of Dock family guanine nucleotide exchange factors
Laurin, M., & Côté, J.-F. (2014) · Genes & Development · doi:10.1101/gad.236349.113 · Cited by 160
Self-citation
Research works printed but not linked: 35
- Buccione, 2004, Foot and mouth: podosomes, invadopodia and circular dorsal ruffles, Nat. Rev. Mol. Cell Biol., 5, 647, 10.1038/nrm1436 · DOI · Paper page
- Colicelli, 2004, Human RAS superfamily proteins and related GTPases, Sci. STKE, 2004, RE13, 10.1126/stke.2502004re13 · DOI · Paper page
- Feng, 2011, Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans, J. Clin. Invest., 121, 4670, 10.1172/JCI58559 · DOI · Paper page
- Feng, 2012, Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis, Proc. Natl. Acad. Sci. USA, 109, 3018, 10.1073/pnas.1121457109 · DOI · Paper page
- Gotoh, 2008, Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells, Blood, 111, 2973, 10.1182/blood-2007-09-112169 · DOI · Paper page
- Gotoh, 2010, Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation, J. Exp. Med., 207, 721, 10.1084/jem.20091776 · DOI · Paper page
- Heid, 2011, Early requirement of Rac1 in a mouse model of pancreatic cancer, Gastroenterology, 141, 719, 10.1053/j.gastro.2011.04.043 · DOI
- Hoon, 2012, Functions and regulation of circular dorsal ruffles, Mol. Cell. Biol., 32, 4246, 10.1128/MCB.00551-12 · DOI · Paper page
- Jarzynka, 2007, ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion, Cancer Res., 67, 7203, 10.1158/0008-5472.CAN-07-0473 · DOI · Paper page
- Kawazu, 2013, Transforming mutations of RAC guanosine triphosphatases in human cancers, Proc. Natl. Acad. Sci. USA, 110, 3029, 10.1073/pnas.1216141110 · DOI · Paper page
- Kissil, 2007, Requirement for Rac1 in a K-ras induced lung cancer in the mouse, Cancer Res., 67, 8089, 10.1158/0008-5472.CAN-07-2300 · DOI · Paper page
- Kunisaki, 2006, DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis, J. Cell Biol., 174, 647, 10.1083/jcb.200602142 · DOI · Paper page
- Lanzetti, 2004, Rab5 is a signalling GTPase involved in actin remodelling by receptor tyrosine kinases, Nature, 429, 309, 10.1038/nature02542 · DOI · Paper page
- Laurin, 2008, The atypical Rac activator Dock180 (Dock1) regulates myoblast fusion in vivo, Proc. Natl. Acad. Sci. USA, 105, 15446, 10.1073/pnas.0805546105 · DOI · Paper page
- Laurin, 2013, Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis, Proc. Natl. Acad. Sci. USA, 110, 7434, 10.1073/pnas.1213050110 · DOI · Paper page
- Li, 2008, Netrin signal transduction and the guanine nucleotide exchange factor DOCK180 in attractive signaling, Nat. Neurosci., 11, 28, 10.1038/nn2022 · DOI
- Malliri, 2002, Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours, Nature, 417, 867, 10.1038/nature00848 · DOI · Paper page
- Nishikimi, 2009, Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis, Science, 324, 384, 10.1126/science.1170179 · DOI · Paper page
- Nishikimi, 2012, Blockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2, Chem. Biol., 19, 488, 10.1016/j.chembiol.2012.03.008 · DOI
- Qiu, 1995, An essential role for Rac in Ras transformation, Nature, 374, 457, 10.1038/374457a0 · DOI · Paper page
- Robinson, 2007, Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES), Biochem. J., 406, 407, 10.1042/BJ20070039 · DOI · Paper page
- Sahai, 2002, RHO-GTPases and cancer, Nat. Rev. Cancer, 2, 133, 10.1038/nrc725 · DOI · Paper page
- Sanematsu, 2010, DOCK180 is a Rac activator that regulates cardiovascular development by acting downstream of CXCR4, Circ. Res., 107, 1102, 10.1161/CIRCRESAHA.110.223388 · DOI · Paper page
- Sanematsu, 2013, Phosphatidic acid-dependent recruitment and function of the Rac activator DOCK1 during dorsal ruffle formation, J. Biol. Chem., 288, 8092, 10.1074/jbc.M112.410423 · DOI · Paper page
- Sanui, 2003, DOCK2 is essential for antigen-induced translocation of TCR and lipid rafts, but not PKC-θ and LFA-1, in T cells, Immunity, 19, 119, 10.1016/S1074-7613(03)00169-9 · DOI · Paper page
- Schmidt, 2002, Guanine nucleotide exchange factors for Rho GTPases: turning on the switch, Genes Dev., 16, 1587, 10.1101/gad.1003302 · DOI · Paper page
- Shirasawa, 1993, Altered growth of human colon cancer cell lines disrupted at activated Ki-ras, Science, 260, 85, 10.1126/science.8465203 · DOI · Paper page
- Spiegel, 2014, Small-molecule modulation of Ras signaling, Nat. Chem. Biol., 10, 613, 10.1038/nchembio.1560 · DOI · Paper page
- Suetsugu, 2003, Differential roles of WAVE1 and WAVE2 in dorsal and peripheral ruffle formation for fibroblast cell migration, Dev. Cell, 5, 595, 10.1016/S1534-5807(03)00297-1 · DOI · Paper page
- Van Aelst, 1997, Rho GTPases and signaling networks, Genes Dev., 11, 2295, 10.1101/gad.11.18.2295 · DOI · Paper page
- Wang, 2010, The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3, Tumour Biol., 31, 59, 10.1007/s13277-009-0009-9 · DOI
- White, 2013, Exploiting the bad eating habits of Ras-driven cancers, Genes Dev., 27, 2065, 10.1101/gad.228122.113 · DOI · Paper page
- Wu, 1978, Mechanism of sensitivity of cultured pancreatic carcinoma to asparaginase, Int. J. Cancer, 22, 728, 10.1002/ijc.2910220615 · DOI · Paper page
- Zhao, 2011, Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival, Histopathology, 59, 1163, 10.1111/j.1365-2559.2011.04045.x · DOI
- Zwartkruis, 2013, Ras and macropinocytosis: trick and treat, Cell Res., 23, 982, 10.1038/cr.2013.79 · DOI
Cited by
Rho GTPase signaling in cancer progression and dissemination
Crosas-Molist, E., Samain, R., Kohlhammer, L., Orgaz, J. L., George, S. L., Maiques, O., Barcelo, J., & Sanz-Moreno, V. (2022) · Physiological Reviews · doi:10.1152/physrev.00045.2020 · Cited by 272
Macropinocytosis: A Metabolic Adaptation to Nutrient Stress in Cancer
Recouvreux, M. V., & Commisso, C. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00261 · Cited by 237
“In addition, it was recently demonstrated that Dock1, a Rac-specific guanine nucleotide exchange factor, is required for oncogenic Rasinduced macropinocytosis in several cancer cells (31).”
BackgroundResultMacropinocytosis confers resistance to therapies targeting cancer anabolism
Jayashankar, V., & Edinger, A. L. (2020) · Nature Communications · doi:10.1038/s41467-020-14928-3 · Cited by 200
Weiss, A., Lorthiois, E., Barys, L., Beyer, K. S., Bomio-Confaglia, C., Burks, H., Chen, X., Cui, X., de Kanter, R., Dharmarajan, L., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0158 · Cited by 150
“To assess the effect of continuous dosing on tumor growth, LU99 tumor–bearing nude mice were implanted subcutaneously with a programmable microin-fusion pump (iPRECIO, SMP310R, Primetech Corporation) as previously described (56).”
Targeting Rac and Cdc42 GEFs in Metastatic Cancer
Maldonado, M. D. M., Medina, J. I., Velazquez, L., & Dharmawardhane, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00201 · Cited by 122
Macropinocytosis, mTORC1 and cellular growth control
Yoshida, S., Pacitto, R., Inoki, K., & Swanson, J. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2710-y · Cited by 114
“Additionally, inhibition of DOCK1, a Rac-activating protein required for macropinocytosis, reduces survival of Ras-driven cell growth [120].”
BackgroundHanada, K., Kawada, K., Nishikawa, G., Toda, K., Maekawa, H., Nishikawa, Y., Masui, H., Hirata, W., Okamoto, M., Kiyasu, Y., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.023 · Cited by 27
Self-citationTomino, T., Tajiri, H., Tatsuguchi, T., Shirai, T., Oisaki, K., Matsunaga, S., Sanematsu, F., Sakata, D., Yoshizumi, T., Maehara, Y., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.073 · Cited by 24
Self-citationLiang, Y., Wang, S., & Zhang, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9077 · Cited by 22
Metadata
- Authors
- Tajiri, H., Uruno, T., Shirai, T., Takaya, D., Matsunaga, S., Setoyama, D., Watanabe, M., Kukimoto-Niino, M., Oisaki, K., Ushijima, M., Sanematsu, F., Honma, T., Terada, T., Oki, E., Shirasawa, S., Maehara, Y., Kang, D., Côté, J.-F., Yokoyama, S., Kanai, M., & Fukui, Y.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 19
- Issue
- 5
- Pages
- 969-980
- ISSN
- 2211-1247
- Cited by
- 57
- References
- 11
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Canadian Institutes of Health Research (MOP-144425)
- Takeda Science Foundation
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science (25251015, 15K06987)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.